Department of Hepato-Pancreato-Biliary and Transplant Surgery, Digestive Disease Institute, Cleveland, Ohio, USA.
Ann Surg. 2012 Mar;255(3):511-6. doi: 10.1097/SLA.0b013e31824682d4.
Intra-abdominal desmoid tumors are one of the leading causes of death in patients with familial adenomatous polyposis. Their behavior is unpredictable and their biology is poorly understood, accounting for the lack of a standardized medical and surgical approach. The aim of this study was to evaluate the mortality rate of patients with intra-abdominal desmoid tumors and to identify prognostic factors for the evolution of the disease.
A total of 154 patients with intra-abdominal desmoid tumors were included in the study. Each tumor was staged and each patient was categorized according to the stage of their most advanced tumor. Mortality was analyzed and the univariate risk factors associated with survival were included in a multivariable Cox regression model. A scoring system was derived from the multivariate analysis to refine outcomes within stages.
Five-year survival of patients with stage I, II, III, and IV intra-abdominal desmoid tumor were 95%, 100%, 89%, and 76% respectively (P < 0.001). Severe pain/narcotic dependency, tumor size larger than 10 cm, and need for total parenteral nutrition were shown to further define survival within stages. Five-year survival rate of stage IV patient with all of the above-mentioned risk factors was only 53%.
Our study confirmed the validity of the staging system to predict mortality in patients with intra-abdominal desmoid tumors and identified additional risk factors able to better define the risk of death within each stage. Risk stratification is crucial in directing patients with advanced disease and poor prognosis to the most appropriate medical and surgical options.
腹内型硬纤维瘤是家族性腺瘤性息肉病患者死亡的主要原因之一。其行为不可预测,生物学特性尚未完全阐明,这导致缺乏标准化的医疗和手术方法。本研究旨在评估腹内型硬纤维瘤患者的死亡率,并确定疾病进展的预后因素。
共纳入 154 例腹内型硬纤维瘤患者。对每个肿瘤进行分期,并根据患者最晚期肿瘤的分期对每个患者进行分类。分析死亡率,并将与生存相关的单因素风险因素纳入多变量 Cox 回归模型。从多变量分析中得出评分系统,以细化各分期内的结果。
Ⅰ期、Ⅱ期、Ⅲ期和Ⅳ期腹内型硬纤维瘤患者的 5 年生存率分别为 95%、100%、89%和 76%(P<0.001)。严重疼痛/需要依赖麻醉性镇痛药、肿瘤直径>10cm 和需要全胃肠外营养进一步定义了各分期内的生存情况。所有上述风险因素的Ⅳ期患者的 5 年生存率仅为 53%。
本研究证实了分期系统预测腹内型硬纤维瘤患者死亡率的有效性,并确定了其他能够更好地定义各分期内死亡风险的额外风险因素。风险分层对于指导晚期疾病和预后不良的患者选择最合适的医疗和手术方案至关重要。